Key Publications
-
Hong, C.W. and Zeng Q. (2012) Awaiting a New Era of Cancer Immunotherapy. Cancer Research 72:3715-3719.
-
Guo, K., Tang, J.P., Jie, L., Al-Aidaroos, A.Q., and Zeng, Q. (2012) Engineering the First Chimeric Antibody in Targeting Intracellular Oncoprotein for Cancer Therapy in Mice. Oncotarget 3:158-171.
-
Zhou, J., Cheong, L.L., Liu, and Chng, W.J. (2012) The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemia. Mol. Cancer 11:72.
-
Guo, K., Li, J., Tang, J.P., Tan, and Zeng, Q. (2011) Targeting Intracellular Oncoproteins with Antibody Therapy or Vaccination. Science Translational Medicine 3(99):99ra85.
Our innovative antibody drugs provide new hope to
hard-to-treat cancer patients.
CONTACT US
Top